JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

CNY 9.85

(0.92%)

EBITDA Summary of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest annual EBITDA in 2023 was 51.04 Million CNY , down -68.23% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 40.21 Million CNY , down -22.98% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported an annual EBITDA of 48.97 Million CNY in 2022, down -6.52% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported an annual EBITDA of 146.55 Million CNY in 2021, down -0.27% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly EBITDA of 29.3 Million CNY for 2024 Q1, up 150.89% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported a quarterly EBITDA of 40.21 Million CNY for 2024 Q3, down -22.98% from previous quarter.

Annual EBITDA Chart of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Historical Annual EBITDA of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Year EBITDA EBITDA Growth
2023 51.04 Million CNY -68.23%
2022 48.97 Million CNY -6.52%
2021 146.55 Million CNY -0.27%
2020 -352.06 Million CNY -78.11%
2019 214.15 Million CNY -16.41%
2018 -96.06 Million CNY -13.17%
2017 310.1 Million CNY 98.05%
2016 159.23 Million CNY -24.29%
2015 205.59 Million CNY -13.24%
2014 258.75 Million CNY -1.47%
2013 240.32 Million CNY 18.07%
2012 189.71 Million CNY 28.43%
2011 134.99 Million CNY -3.21%
2010 125.03 Million CNY 40.99%
2009 106.38 Million CNY 0.93%
2008 111.87 Million CNY 21.53%
2007 56.26 Million CNY -26.32%
2006 132.98 Million CNY -3.53%
2005 127.51 Million CNY -12.46%
2004 157.96 Million CNY 23.37%
2003 127.18 Million CNY 13.17%
2002 113.25 Million CNY -10.28%
2001 125.26 Million CNY 51.74%
2000 74.67 Million CNY 89.84%
1999 43.8 Million CNY 3.49%
1998 39.37 Million CNY 37.88%
1997 30.47 Million CNY -16.58%
1996 36.52 Million CNY 0.0%

Peer EBITDA Comparison of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Name EBITDA EBITDA Difference
Beijing Tiantan Biological Products Co., Ltd. 2.07 Billion CNY 97.535%
Jinyu Bio-technology Co., Ltd. 502.66 Million CNY 89.846%
Vcanbio Cell & Gene Engineering Corp., Ltd 277.1 Million CNY 81.581%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 1.9 Billion CNY 97.315%
Zhejiang Ausun Pharmaceutical Co., Ltd. 339.62 Million CNY 84.971%
DaShenLin Pharmaceutical Group Co., Ltd. 3.59 Billion CNY 98.582%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 1.65 Billion CNY 96.92%
GuiZhou SanLi Pharmaceutical Co.,Ltd 369.18 Million CNY 86.175%
Pulike Biological Engineering, Inc. 288.26 Million CNY 82.294%
Beijing Konruns Pharmaceutical Co.,Ltd. 188.49 Million CNY 72.921%
Shanghai Hile Bio-Technology Co., Ltd. 101.11 Million CNY 49.524%
Qingdao Vland Biotech INC. 217.9 Million CNY 76.576%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 379.57 Million CNY 86.553%
Aurisco Pharmaceutical Co.,Ltd. 414.37 Million CNY 87.682%
Zhejiang East Asia Pharmaceutical Co., Ltd. 253.19 Million CNY 79.841%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 213.41 Million CNY 76.083%
Mabwell (Shanghai) Bioscience Co., Ltd. -929.77 Million CNY 105.49%
Beijing Hotgen Biotech Co., Ltd. 85.04 Million CNY 39.98%
Assure Tech (Hangzhou) Co., Ltd. 217.59 Million CNY 76.543%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 324.76 Million CNY 84.284%
Cabio Biotech (Wuhan) Co., Ltd. 152.91 Million CNY 66.622%
Shanghai Shen Lian Biomedical Corporation 99.74 Million CNY 48.827%
Nanjing Vazyme Biotech Co., Ltd. 156.12 Million CNY 67.308%
Shandong Kexing Bioproducts Co,.Ltd -119.68 Million CNY 142.648%
Shanghai Junshi Biosciences Co., Ltd. -2.15 Billion CNY 102.366%
Shanghai Model Organisms Center, Inc. 40.71 Million CNY -25.357%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. -214.22 Million CNY 123.826%
Xiamen Amoytop Biotech Co., Ltd. 709.65 Million CNY 92.808%
Novogene Co., Ltd. 369.4 Million CNY 86.183%
Shanghai ZJ Bio-Tech Co., Ltd. -88.77 Million CNY 157.492%
Chengdu Olymvax Biopharmaceuticals Inc. 56.81 Million CNY 10.157%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 424.7 Million CNY 87.982%
Shanghai Haohai Biological Technology Co., Ltd. 712.95 Million CNY 92.841%
Jiangsu Bioperfectus Technologies Co., Ltd. -255.06 Million CNY 120.011%
Jiangsu Aidea Pharmaceutical Co., Ltd. -39.29 Million CNY 229.89%
Chengdu Easton Biopharmaceuticals Co., Ltd. 318.28 Million CNY 83.964%
Sinocelltech Group Limited -164.45 Million CNY 131.036%
Wuhan Keqian Biology Co.,Ltd 580 Million CNY 91.2%
Shanghai Allist Pharmaceuticals Co., Ltd. 696.61 Million CNY 92.673%
Anhui Huaheng Biotechnology Co., Ltd. 618.3 Million CNY 91.745%
Youcare Pharmaceutical Group Co., Ltd. 418.36 Million CNY 87.8%
Jiangsu gdk Biotechnology Co., Ltd. -54.8 Million CNY 193.135%
Beijing Kawin Technology Share-Holding Co., Ltd. 187.82 Million CNY 72.825%
Hangzhou Biotest Biotech Co.,Ltd. 146.45 Million CNY 65.148%